Literature DB >> 18097796

Development of an optimal antigen retrieval protocol for immunohistochemistry of retinoblastoma protein (pRB) in formalin fixed, paraffin sections based on comparison of different methods.

S R Shi1, C Liu, L Young, Cr Taylor.   

Abstract

A novel protocol for antigen retrieval (AR) for immunohistochemistry (IHC) of retinoblastoma protein (pRB) in formalin fixed, paraffin embedded (FFPE) tissue sections was developed using 0.05% citraconic anhydride as the AR solution for heat treatment based on comparison of different methods. This new protocol has advantages including superior morphological preservation, greater reproducibility, and more intense staining after retrieval. Our study demonstrates the importance of comparing various AR protocols to obtain maximal IHC for standardization and for quantitative IHC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18097796     DOI: 10.1080/10520290701791763

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  5 in total

1.  An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition.

Authors:  Ayesha T Chawla; Agnes D Cororaton; Michael O Idowu; Priyadarshan K Damle; Barbara Szomju; Keith C Ellis; Bhaumik B Patel; Steven R Grossman
Journal:  Oncotarget       Date:  2018-08-21

2.  CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma.

Authors:  Ayesha T Chawla; Kranthi Kumar Chougoni; Prashant J Joshi; Agnes D Cororaton; Patrick Memari; John C Stansfield; Haemin Park; Rashmi Seth; Barbara Szomju; Adam P Sima; Michael O Idowu; Keith C Ellis; Steven R Grossman
Journal:  Oncogenesis       Date:  2019-10-04       Impact factor: 7.485

3.  The role of exogenous epidermal growth factor on Ki-67 proliferation marker expression in the submandibular salivary gland of albino rats receiving doxorubicin.

Authors:  Mohamed Mansy; Malak Soliman; Rabab Mubarak; Mohamed Shamel
Journal:  F1000Res       Date:  2020-12-03

4.  GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells.

Authors:  Xiufei Gao; Zimei Yang; Chuchu Xu; Qinghong Yu; Mengqian Wang; Jiaqing Song; Chunyu Wu; Mingcang Chen
Journal:  Ann Transl Med       Date:  2022-03

5.  IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer.

Authors:  Yunxia Zhang; Jing Wang; Di Wu; Miao Li; Fenshu Zhao; Mulan Ren; Yunlong Cai; Jun Dou
Journal:  Onco Targets Ther       Date:  2018-04-10       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.